{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 16538,
  "pageSize": 18,
  "pageCount": 17777,
  "rows": [
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/11",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 11,
          "beatId": "658ab0ae-6284-4b3b-b67a-e6c8bfbdd666",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 11-16 present APX3330 as a solution for Diabetic Retinopathy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/12",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 11,
          "beatId": "658ab0ae-6284-4b3b-b67a-e6c8bfbdd666",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 11-16 present APX3330 as a solution for Diabetic Retinopathy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/13",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 11,
          "beatId": "658ab0ae-6284-4b3b-b67a-e6c8bfbdd666",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 11-16 present APX3330 as a solution for Diabetic Retinopathy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/14",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 11,
          "beatId": "658ab0ae-6284-4b3b-b67a-e6c8bfbdd666",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 11-16 present APX3330 as a solution for Diabetic Retinopathy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/15",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 11,
          "beatId": "658ab0ae-6284-4b3b-b67a-e6c8bfbdd666",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 11-16 present APX3330 as a solution for Diabetic Retinopathy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/16",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-16",
      "loopMatches": [
        {
          "to": 18,
          "from": 16,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "06b3bd6b-dd7a-4246-9ad5-76e883655757",
          "evidence": "Slides 16-18 highlight APX3330's mechanism of action and in-vitro validation",
          "position": 0,
          "objective": "What makes APX3330 unique?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 11,
          "beatId": "658ab0ae-6284-4b3b-b67a-e6c8bfbdd666",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 11-16 present APX3330 as a solution for Diabetic Retinopathy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "timeline",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/17",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-17",
      "loopMatches": [
        {
          "to": 18,
          "from": 16,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "06b3bd6b-dd7a-4246-9ad5-76e883655757",
          "evidence": "Slides 16-18 highlight APX3330's mechanism of action and in-vitro validation",
          "position": 0,
          "objective": "What makes APX3330 unique?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/18",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-18",
      "loopMatches": [
        {
          "to": 18,
          "from": 16,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "06b3bd6b-dd7a-4246-9ad5-76e883655757",
          "evidence": "Slides 16-18 highlight APX3330's mechanism of action and in-vitro validation",
          "position": 0,
          "objective": "What makes APX3330 unique?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/19",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/20",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "other",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/21",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "other",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/22",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "other",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/23",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/24",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/25",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "other",
      "function": "analyze_data",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/26",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "other",
      "function": "analyze_data",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/27",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de517-75a1-7387-968b-d0dc513bf421",
      "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
      "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
      "authorId": "ocuphire-pharma",
      "authorName": "Ocuphire Pharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/28",
      "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
      "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 17,
          "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}